BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22056774)

  • 1. Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein.
    Lee HR; Choi WC; Lee S; Hwang J; Hwang E; Guchhait K; Haas J; Toth Z; Jeon YH; Oh TK; Kim MH; Jung JU
    Nat Struct Mol Biol; 2011 Nov; 18(12):1336-44. PubMed ID: 22056774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathway.
    Lee HR; Toth Z; Shin YC; Lee JS; Chang H; Gu W; Oh TK; Kim MH; Jung JU
    J Virol; 2009 Jul; 83(13):6739-47. PubMed ID: 19369353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the p53/MDM2 interplay by HAUSP inhibitors.
    Tavana O; Gu W
    J Mol Cell Biol; 2017 Feb; 9(1):45-52. PubMed ID: 27927749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model.
    Becker K; Marchenko ND; Palacios G; Moll UM
    Cell Cycle; 2008 May; 7(9):1205-13. PubMed ID: 18418047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HAUSP, a novel deubiquitinase for Rb - MDM2 the critical regulator.
    Bhattacharya S; Ghosh MK
    FEBS J; 2014 Jul; 281(13):3061-78. PubMed ID: 24823443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p53--Mdm2--HAUSP complex is involved in p53 stabilization by HAUSP.
    Brooks CL; Li M; Hu M; Shi Y; Gu W
    Oncogene; 2007 Nov; 26(51):7262-6. PubMed ID: 17525743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway.
    Hu M; Gu L; Li M; Jeffrey PD; Gu W; Shi Y
    PLoS Biol; 2006 Feb; 4(2):e27. PubMed ID: 16402859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of HAUSP in vivo modulates p53 function.
    Kon N; Kobayashi Y; Li M; Brooks CL; Ludwig T; Gu W
    Oncogene; 2010 Mar; 29(9):1270-9. PubMed ID: 19946331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-terminal region of USP7/HAUSP is critical for deubiquitination activity and contains a second mdm2/p53 binding site.
    Ma J; Martin JD; Xue Y; Lor LA; Kennedy-Wilson KM; Sinnamon RH; Ho TF; Zhang G; Schwartz B; Tummino PJ; Lai Z
    Arch Biochem Biophys; 2010 Nov; 503(2):207-12. PubMed ID: 20816748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dynamic role of HAUSP in the p53-Mdm2 pathway.
    Li M; Brooks CL; Kon N; Gu W
    Mol Cell; 2004 Mar; 13(6):879-86. PubMed ID: 15053880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HAUSP-nucleolin interaction is regulated by p53-Mdm2 complex in response to DNA damage response.
    Lim KH; Park JJ; Gu BH; Kim JO; Park SG; Baek KH
    Sci Rep; 2015 Aug; 5():12793. PubMed ID: 26238070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Kaposi Sarcoma Herpesvirus (KSHV) vIRF1 Protein as a Novel Interaction Partner of Human Deubiquitinase USP7.
    Chavoshi S; Egorova O; Lacdao IK; Farhadi S; Sheng Y; Saridakis V
    J Biol Chem; 2016 Mar; 291(12):6281-91. PubMed ID: 26786098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HAUSP is required for p53 destabilization.
    Cummins JM; Vogelstein B
    Cell Cycle; 2004 Jun; 3(6):689-92. PubMed ID: 15118411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-B-associated transcript 3 (Bat3) stabilizes and activates p53 in a HAUSP-dependent manner.
    Zhang R; Cui D; Xue T; Lang Y; Zhang Y; Li L; Sun H; Kuang Y; Li G; Tang J
    J Mol Cell Biol; 2020 Feb; 12(2):99-112. PubMed ID: 31647545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular recognition of p53 and MDM2 by USP7/HAUSP.
    Sheng Y; Saridakis V; Sarkari F; Duan S; Wu T; Arrowsmith CH; Frappier L
    Nat Struct Mol Biol; 2006 Mar; 13(3):285-91. PubMed ID: 16474402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization.
    Li M; Chen D; Shiloh A; Luo J; Nikolaev AY; Qin J; Gu W
    Nature; 2002 Apr; 416(6881):648-53. PubMed ID: 11923872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
    Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
    Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation.
    Meulmeester E; Pereg Y; Shiloh Y; Jochemsen AG
    Cell Cycle; 2005 Sep; 4(9):1166-70. PubMed ID: 16082221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p53 tumor suppressor is stabilized by inhibitor of growth 1 (ING1) by blocking polyubiquitination.
    Thalappilly S; Feng X; Pastyryeva S; Suzuki K; Muruve D; Larocque D; Richard S; Truss M; von Deimling A; Riabowol K; Tallen G
    PLoS One; 2011; 6(6):e21065. PubMed ID: 21731648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (1)H, (13)C and (15)N backbone resonance assignment for the 40.5 kDa catalytic domain of Ubiquitin Specific Protease 7 (USP7).
    Di Lello P; Rougé L; Pan B; Maurer T
    Biomol NMR Assign; 2016 Oct; 10(2):345-9. PubMed ID: 27386854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.